1.730
−1,14%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -500.1% | -736.2% | 0 / 3 | -4.2% | +1.27 pp | -9.80 pp | -1.8% | 0.54 | — | 197 | −4,2% | −7,5 | −161,1% | — | -17.26 | — |
| Pts | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.730 (close price on 2026-10-19)EPS (TTM): −183,1
Financial charts
1.Revenue & growth
VND bn197Q2/26
1.Revenue & growth
VND bn197Q2/26
2.Profit & growth
VND bn-4,50Q2/26
3.Profit mix (Penman)
VND bn-31,3Q2/26
4.Margins & cost structure
%21.5%Q2/26
5.Returns & cash cycle
% · days-0.8%Q2/26
6.Earnings quality & cash
VND bn696Q2/26
7.Asset structure
VND bn3.950Q2/26
8.Funding & debt health
VND bn · times3.950Q2/26
9.Revenue backlog
VND bn3,64Q2/26
10.Valuation
times · %-11,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-23Q2/26
Adjusted EPS growth, latest quarter
-500%
Average adjusted EPS growth, 3 quarters
-725%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26